(Q93694113)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4098905%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

title

Distinctions in chronic active hepatitis based on circulating hepatitis-associated antigen (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4098905%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

author name string

B H Bulkley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4098905%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

S E Goldfinger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4098905%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

W D Heizer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4098905%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

K J Isselbacher

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4098905%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

N R Shulman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4098905%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

publication date

1 December 1970

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4098905%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4098905%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4098905%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

page(s)

1323-1326

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4098905%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

issue

7687

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4098905%20AND%20SRC:MED&resulttype=core&format=json

The course of infectious hepatitis with special reference to prognosis and the chronic stage

9 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

The problem of chronic liver disease in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

Hepatitis, colitis, and lupus manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

CHRONIC ACTIVE ("LUPOID") HEPATITIS; A CLINICAL, SEROLOGICAL, AND PATHOLOGICAL STUDY OF 20 PATIENTS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

Natural history of active chronic hepatitis. II. Pathology, pathogenesis and clinico-pathological correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

Natural history of active chronic hepatitis. I. Clinical features, course, diagnostic criteria, morbidity, mortality and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

Active chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

1 reference

7 January 2021

Hepatitis and cirrhosis in women with positive clot tests for lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

SEROLOGICAL ABNORMALITIES IN PATIENTS WITH LIVER DISEASE

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

A classification of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

Prognosis of chronic persistent hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

A "NEW" ANTIGEN IN LEUKEMIA SERA

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

An antigen detected in the blood during the incubation period of serum hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

Australia antigen and acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

Hepatitis antigen. Correlation with disease and infectivity of blood-donors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

1 reference

7 January 2021

Australia antigen in acute and chronic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

Australia antigen in chronic active liver disease with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

Virus-like antigen, antibody, and antigen-antibody complexes in hepatitis measured by complement fixation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

Two new antinuclear antibodies: their relationship to the homogeneous immunofluorescent pattern.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

Post-hepatitis cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

Subacute hepatic necrosis and postnecrotic cirrhosis due to anicteric infections with the hepatitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

Anicteric viral hepatitis. A clinicopathological follow-up study in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

Progression of acute hepatitis to postnecrotic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

Relation of Australia-SH antigen to the willowbrook MS-2 strain.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

Hepatitis-associated antigen in chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

Experimental viral hepatitis in the dog: production of persistent disease in partially immune animals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

Immune complexes in hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992356-1

7 January 2021

10.1016/S0140-6736(70)92356-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4098905%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

1 reference